Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
421 articles
Large clinical trial finds popular diabetes drug semaglutide ineffective at slowing Alzheimer's progression in early-stage patients.
Rare liver disease affects bile ducts, strongly linked to inflammatory bowel disease and increased cancer risk.
Major UK trial finds proton therapy offers similar outcomes to standard radiation for oropharyngeal cancer patients.
New research examines proton therapy's effectiveness for throat cancer, focusing on survival rates and reduced side effects.
Scientists respond to questions about dual antiplatelet therapy versus aspirin alone for heart bypass patients.
Artificial intelligence analyzes standard electrocardiograms to identify septal fibrosis, potentially revolutionizing heart health screening.
Artificial intelligence shows promise in identifying septal fibrosis using standard electrocardiograms, potentially revolutionizing cardiac screening.
New oral formulations of popular GLP-1 medications may eliminate the need for weekly injections while maintaining benefits.
New study reveals bleeding complications after heart procedure affect nearly 1 in 5 patients, with highest risk in first 6 months.
New research reveals finerenone may reduce new-onset atrial fibrillation in heart failure patients with preserved ejection fraction.
New analysis reveals oral semaglutide significantly reduces cardiovascular risk factors beyond blood sugar control in type 2 diabetes.
Major study analyzes survival outcomes when cardiac arrest complicates heart attack shock, revealing key patterns for emergency care.
